3Etienne Chatelut,Taehee Kim,Sinil Kim. A slow-release methotrexate formulation for intrathecal chemotherapy[J] 1993,Cancer Chemotherapy and Pharmacology(3):179～182
4Taehee Kim,Joon Kim,Sinil Kim. Extended-release formulation of morphine for subcutaneous administration[J] 1993,Cancer Chemotherapy and Pharmacology(3):187～190
5Andrea Bonetti,Sinil Kim. Pharmacokinetics of an extended-release human interferon alpha-2b formulation[J] 1993,Cancer Chemotherapy and Pharmacology(3):258～261
6Romi Roy,Sinil Kim. Multivesicular liposomes containing bleomycin for subcutaneous administration[J] 1991,Cancer Chemotherapy and Pharmacology(2):105～108
二级参考文献2
1Katre NV,Asherman J,Schaffer H,et al.Multivesicular liposome(DepoFoam) technolofy for the sustained delivery of insulin-like growth factor-I (IGF-I)[].Journal of Pharmacological Sciences.1998
7Jain SK, Jain RK, Chourasia MK, et al. Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium [J]. AAPSPharmSciTech, 2005, 6 (1) : E35-E41.
8Li H, An JH, Park JS, et al. Multivesicular liposomes for oral delivery of recombinant human epidermal growth factor [J]. Arch Pharm Res, 2005, 28 (8) : 988-994.
9Kim S, Howell SB. Method for treating neurological disorders: US, 5455044 [P]. 1995-10-03.
10Ye Q, Sankaram MB. Method for producing liposomes with increased percent of compound encapsulated: US, 5997899 [P]. 1999-12-07.
